Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (Nav) in peripheral neurons, specifically the Nav1.7, Nav1.8, and Nav1.9 subtypes, are essential proteins for the initiation and propagation of electrical signals in the peripheral nervous system [Source: Nature Reviews Neuroscience, 2013]. These channels are primarily expressed in nociceptors within the dorsal root ganglia and are responsible for transmitting pain signals from the periphery to the central nervous system. Nav1.7 acts as a threshold setter, Nav1.8 contributes significantly to the action potential upstroke, and Nav1.9 regulates resting membrane potential and excitability [Source: The Lancet Neurology, 2014]. Mutations in the genes encoding these channels (SCN9A, SCN10A, SCN11A) are directly linked to human pain disorders, such as erythromelalgia and congenital insensitivity to pain, making them high-value targets for analgesic development. Therapeutic strategies focus on developing isoform-selective inhibitors, such as the Nav1.8-selective blocker suzetrigine, to provide effective pain relief while minimizing side effects associated with non-selective sodium channel inhibition in the heart or brain [Source: New England Journal of Medicine, 2024]. By targeting channels localized to the peripheral nervous system, researchers aim to avoid the dose-limiting toxicities of traditional sodium channel blockers like lidocaine or carbamazepine. Overall, peripheral Nav channels represent a validated and promising class of targets for the next generation of non-opioid pain management therapies.
Inhibition of sodium ion influx through the alpha-subunit pore of the channel, which prevents membrane depolarization and the subsequent generation and conduction of action potentials in peripheral sensory neurons [Source: Nature Reviews Drug Discovery, 2018].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel (Nav) (Nav).